Physician profile
Maria A Lascuna
NPI 1366584534
$5,514.04
in general payments reported to CMS, 2019-2025
32 companies · $1,007 in 2025
The $1,007 reported for 2025 was more than what 91% of Community Health (Nurse Practitioner) providers received nationally (typical 2025 total: $139).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,210 · 2022: $990 · 2023: $1,077 · 2024: $1,230 · 2025: $1,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,313.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,735.30 | 2021-2025 | Tezspire, Repatha, Otezla |
| Glaxosmithkline, LLC. | $839.18 | 2021-2025 | Trelegy Ellipta, Nucala |
| Lilly USA, LLC | $401.34 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $334.65 | 2021-2024 | Tezspire, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.66 | 2021-2022 | |
| Novo Nordisk INC | $268.11 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Ardelyx, INC. | $167.03 | 2025 | Ibsrela |
| Otsuka America Pharmaceutical, INC. | $161.23 | 2021-2024 | Rexulti |
| Abbvie INC. | $148.94 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $134.44 | 2022 | |
| Becton, Dickinson and Company | $125.11 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $111.13 | 2023-2024 | Dupixent |
| Dexcom, INC. | $77.52 | 2021-2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $66.53 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.15 | 2021-2024 | Xifaxan |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $62.89 | 2021 | |
| Shield Therapeutics INC | $58.12 | 2024-2025 | |
| Sanofi Pasteur INC. | $53.62 | 2023 | |
| Philips North America LLC | $45.99 | 2025 | Vest Therapy Und |
| Biohaven Pharmaceutical Holding Company Ltd. | $42.40 | 2022 | |
| Merck Sharp & Dohme LLC | $39.74 | 2021 | |
| Xeris Pharmaceuticals, INC. | $39.62 | 2024 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $38.52 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.28 | 2022 | |
| Cranial Technologies, INC | $34.27 | 2025 | Doc Band |
| Lifescan, INC. | $24.93 | 2022 | |
| Nevro Corp. | $23.67 | 2022 | |
| Esperion Therapeutics, INC. | $22.24 | 2024 | Nexletol |
| Exact Sciences Corporation | $22.20 | 2024 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.98 | 2022 | |
| Phathom Pharmaceuticals, INC. | $14.95 | 2025 | Voquezna |
| Corcept Therapeutics | $14.30 | 2024 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Lascuna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.